While Hamburg Focuses On Drugs, India Demands Devices
This article was originally published in The Gray Sheet
Executive Summary
There are lots of growth opportunities and new regulatory initiatives for devices in India, affirms a report by o3 Capital Global Advisory Private Limited, an Indian investment banking firm. But device-related issues are not high on the agenda of FDA Commissioner Hamburg during her trip to the country concluding Feb. 18.